Mechanistic Understanding of Enhanced Human Oral Bioavailability of Fenofibric Acid from Novel Lipid Carriers Using Semi-physiologically Based Pharmacokinetic Model and Various Analytical Approaches Including Biorelevant Dissolution Testing